Convatec Group PLC Logo

Convatec Group PLC

ISIN: GB00BD3VFW73 | Ticker: CTEC | LEI: 213800LS272L4FIDOH92
Sector: Health CareSub-Industry: Health Care Supplies
Country: United Kingdom

About Convatec Group PLC

Company Description

Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care and infusion care.

Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.

Year founded

1978

Served area

Worldwide

Headcount

10,000

Headquarters

3 Forbury Place, 23 Forbury Road, RG1 3JH Reading – United Kingdom

Financial statements

Download as Excel
Line item in (usd) 01.01.2021 01.01.2022 01.01.2023
Assets N/A 3,674,000,000.00 3,592,000,000.00
Noncurrent Assets N/A 2,563,200,000.00 2,702,700,000.00
Property Plant And Equipment N/A 366,700,000.00 400,400,000.00
Other Noncurrent Receivables N/A 11,900,000.00 8,600,000.00
Deferred Tax Assets N/A 28,900,000.00 26,600,000.00
Noncurrent Restricted Cash And Cash Equivalents N/A 13,600,000.00 7,300,000.00
Noncurrent Derivative Financial Assets N/A 0.00 200,000.00
Current Assets N/A 1,110,800,000.00 889,300,000.00
Inventories N/A 308,800,000.00 336,900,000.00
Cash and cash equivalents 565,400,000.00 463,400,000.00 143,800,000.00
Current Restricted Cash And Cash Equivalents N/A 0.00 18,200,000.00
Current Derivative Financial Assets N/A 15,100,000.00 26,400,000.00
Equity And Liabilities N/A 3,674,000,000.00 3,592,000,000.00
Equity 1,670,700,000.00 1,694,800,000.00 1,609,700,000.00
Issued Capital N/A 247,000,000.00 250,700,000.00
Retained Earnings N/A -842,000,000.00 -892,200,000.00
Share Premium N/A 142,300,000.00 165,700,000.00
Treasury Shares N/A 2,200,000.00 1,500,000.00
Other Reserves N/A 126,500,000.00 165,200,000.00
Merger Reserve N/A 2,098,900,000.00 2,098,900,000.00
Liabilities N/A 1,979,200,000.00 1,982,300,000.00
Noncurrent Liabilities N/A 1,410,000,000.00 1,449,200,000.00
Noncurrent Provisions N/A 1,700,000.00 53,100,000.00
Other Noncurrent Payables N/A 47,600,000.00 32,700,000.00
Deferred Tax Liabilities N/A 87,200,000.00 83,200,000.00
Noncurrent Derivative Financial Liabilities N/A 2,900,000.00 300,000.00
Longterm Borrowings N/A 1,199,800,000.00 1,211,900,000.00
Current Liabilities N/A 569,200,000.00 533,100,000.00
Current Provisions N/A 5,000,000.00 100,200,000.00
Trade And Other Current Payables N/A 342,500,000.00 346,600,000.00
Current Tax Liabilities Current N/A 45,500,000.00 33,500,000.00
Current Derivative Financial Liabilities N/A 11,700,000.00 32,500,000.00
Line item in (usd) 01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 2,038,300,000.00 2,072,500,000.00
Profit Loss From Operating Activities 203,600,000.00 207,300,000.00
Finance Income 800,000.00 5,500,000.00
Finance Costs 44,300,000.00 73,200,000.00
Profit Loss Before Tax 151,300,000.00 81,900,000.00
Income Tax Expense Continuing Operations 33,700,000.00 19,000,000.00
Profit (loss) 117,600,000.00 62,900,000.00
Line item in (usd) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 117,600,000.00 62,900,000.00
Adjustments For Income Tax Expense N/A 33,700,000.00 19,000,000.00
Adjustments For Decrease Increase In Inventories N/A -19,600,000.00 -36,300,000.00
Adjustments For Sharebased Payments N/A 16,400,000.00 16,700,000.00
Cash Flows From Used In Operations N/A 400,600,000.00 384,500,000.00
Interest Paid Classified As Operating Activities N/A 36,300,000.00 55,400,000.00
Interest Received Classified As Operating Activities N/A 800,000.00 5,500,000.00
Cash Flows From Used In Operating Activities N/A 305,900,000.00 281,700,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 113,800,000.00 123,300,000.00
Cash Flows From Used In Investing Activities N/A -206,500,000.00 -348,300,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 491,800,000.00 714,200,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 583,900,000.00 842,500,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 22,000,000.00 20,700,000.00
Dividends Paid Classified As Financing Activities N/A 85,800,000.00 88,100,000.00
Cash Flows From Used In Financing Activities N/A -199,900,000.00 -237,100,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A -100,500,000.00 -303,700,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -1,500,000.00 -15,900,000.00
Cash and cash equivalents 565,400,000.00 463,400,000.00 143,800,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
Kintbury Capital LLP 0.52% 18.10.23
AKO Capital LLP 1.44% 09.08.23
AKO Capital LLP 0.74% 30.04.24
GLG Partners LP 0.54% 12.01.24
Kintbury Capital LLP 0.70% 24.10.23
AQR Capital Management, LLC 0.50% 12.09.23
GLG Partners LP 0.69% 06.02.24
AKO Capital LLP 1.50% 16.11.23
GLG Partners LP 0.66% 25.01.24
AKO Capital LLP 1.37% 25.04.24
GLG Partners LP 0.70% 01.02.24
AKO Capital LLP 0.54% 16.05.24
Total 9.90%

Capital markets information

ISIN

GB00BD3VFW73

LEI

213800LS272L4FIDOH92

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 100

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.